Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Undecaprenyl-diphosphate phosphatase (UppP), also known as BacA, is an essential integral membrane enzyme in bacteria that catalyzes the dephosphorylation of undecaprenyl diphosphate (UPP) to undecaprenyl phosphate (UP) [1][2]. This enzymatic step is a critical bottleneck in the peptidoglycan biosynthesis pathway, as UP serves as the vital C55-lipid carrier that transports sugar-peptide precursors across the cytoplasmic membrane to the growing cell wall [3]. By recycling UPP—which is generated both de novo and as a byproduct of peptidoglycan polymerization—UppP maintains the steady-state levels of UP necessary for continuous cell wall assembly [2][4]. Inhibition of this process leads to the depletion of the lipid carrier pool, resulting in the cessation of cell wall synthesis and subsequent bacterial cell death [3]. While the classic antibiotic bacitracin targets this pathway by sequestering the UPP substrate, UppP itself is a primary target for developing new antimicrobial strategies to combat multi-drug resistant pathogens [1][4]. Because the peptidoglycan synthesis machinery is unique to bacteria, UppP offers a high degree of selectivity with minimal potential for off-target effects in human hosts [2].
Inhibition of undecaprenyl phosphate recycling by preventing the dephosphorylation of undecaprenyl diphosphate, thereby halting peptidoglycan precursor transport and cell wall synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Undecaprenyl-diphosphate phosphatase (UppP).